1. Home
  2. GCT vs SVRA Comparison

GCT vs SVRA Comparison

Compare GCT & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GigaCloud Technology Inc

GCT

GigaCloud Technology Inc

HOLD

Current Price

$32.60

Market Cap

1.2B

ML Signal

HOLD

Logo Savara Inc.

SVRA

Savara Inc.

HOLD

Current Price

$5.98

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCT
SVRA
Founded
2019
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
GCT
SVRA
Price
$32.60
$5.98
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$33.00
$7.33
AVG Volume (30 Days)
728.0K
2.0M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
17.70
N/A
EPS
1.04
N/A
Revenue
$1,161,042,000.00
N/A
Revenue This Year
$14.43
N/A
Revenue Next Year
$6.78
$430.87
P/E Ratio
$30.80
N/A
Revenue Growth
64.96
N/A
52 Week Low
$19.54
$1.98
52 Week High
$51.82
$7.01

Technical Indicators

Market Signals
Indicator
GCT
SVRA
Relative Strength Index (RSI) 40.85 68.32
Support Level $31.08 $5.86
Resistance Level $34.46 $6.15
Average True Range (ATR) 1.57 0.28
MACD 0.20 0.08
Stochastic Oscillator 26.91 84.98

Price Performance

Historical Comparison
GCT
SVRA

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: